Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-002421

Director sold 5,000 shares at $30.00 ($150,000)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DOBMEIER ERIC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-31 Exercise or conversion : show line 1 in the form +5,000 $6.32 $31,600 5,000 D
2019-12-31 Sale : show line 2 in the form −5,000 $30.00 $150,000 0 D
Open-market sales · 5,000 sh · avg $30.00 · $150,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-31 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,000 80,000 D
Loading xslF345X03/doc4a.xml…